INR 686.85
(9.48%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -830.93 Million INR | -34.03% |
2022 | -619.98 Million INR | -6.79% |
2021 | -580.56 Million INR | -510.34% |
2020 | -95.12 Million INR | -114.09% |
2019 | 674.93 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -287.52 Million INR | -108.98% |
2024 Q1 | 3.2 Billion INR | 485.34% |
2023 Q2 | -697.03 Million INR | -8.68% |
2023 Q4 | -830.93 Million INR | -129.37% |
2023 FY | -830.93 Million INR | -34.03% |
2023 Q3 | 2.82 Billion INR | 505.95% |
2023 Q1 | -641.36 Million INR | -3.45% |
2022 Q4 | -619.98 Million INR | 0.0% |
2022 FY | -619.98 Million INR | -6.79% |
2022 Q2 | - INR | 100.0% |
2022 Q1 | -857.13 Million INR | 0.0% |
2021 FY | -580.56 Million INR | -510.34% |
2020 FY | -95.12 Million INR | -114.09% |
2019 FY | 674.93 Million INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.35 Billion INR | 161.333% |
Biocon Limited | 140.18 Billion INR | 100.593% |
Concord Biotech Limited | -372.86 Million INR | -122.848% |
Dishman Carbogen Amcis Limited | 18.99 Billion INR | 104.375% |
FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 175.237% |
GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | -1368046.345% |
Lyka Labs Limited | 527.01 Million INR | 257.668% |
Panacea Biotec Limited | -1.18 Billion INR | 29.873% |
SAMSRITA LABS LIMITED | 21.98 Million INR | 3878.796% |
Servoteach Industries Limited | 5016.00 INR | 16565690.132% |
SMS Lifesciences India Limited | 992.31 Million INR | 183.737% |
Supriya Lifescience Limited | -694.68 Million INR | -19.613% |
Syngene International Limited | -83 Million INR | -901.12% |
TAKE Solutions Limited | 361.37 Million INR | 329.939% |
Titan Biotech Limited | 54.62 Million INR | 1621.07% |
Transgene Biotek Limited | 139.93 Million INR | 693.806% |
Vanta Bioscience Limited | 607.93 Million INR | 236.682% |